Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis-Reference-Cited by-同舟云学术

Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

Published:2008-11-24 Issue:12 Volume:14 Page:1766-1777
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Roche Bruno,Sebagh Mylene,Canfora Maria Laura,Antonini Teresa,Roque-Afonso Anne-Marie,Delvart Valerie,Saliba Faouzi,Duclos-Vallee Jean-Charles,Castaing Denis,Samuel Didier

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21635/fullpdf

Reference35 articles.

1. Long-term outcome of hepatitis C infection after liver transplantation;Gane;N Engl J Med,1996

2. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C;Feray;Gastroenterology,1999

3. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

4. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

5. combination of interferon alpha-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C;Firpi;Liver Transpl,2002

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms;Frontiers in Pharmacology;2024-05-23

2. Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications;Experimental and Clinical Transplantation;2021-09

3. Обзор исследований прогрессии фиброза печёночной ткани после трансплантации печени;Естественные и Технические Науки;2021

4. Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis;Liver Transplantation;2020-12-29

5. Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy;Journal of Clinical and Translational Hepatology;2019-06-04